Longbio Pharma Opens Public Offering: Premium Pipeline in Autoimmune & Allergic Diseases Fuels Long-Term Growth HealthCare May 29, 2026 Driven by national industrial policy support and the comprehensive upgrading of public health needs, China’s biopharmaceutical industry has entered a…
